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Abstract
Thanks to the technological innovations introduced in the biological research pipeline, it is possible to write a list of parts
containing the molecular units building living systems. This list constitutes the starting point for Systems Biology, a new
paradigmatic approach in life sciences, that focuses on the complex behaviors of living systems deriving from the interactions
of their molecular basis. In this way biological systems are represented as networks of interacting entities. Computational models
of biological networks will help us to deeply understand the development of living organisms. In this paper we first introduce a
general graph based model of biological systems and we then focus our attention on metabolic networks. We show how metabolic
networks optimization techniques based on linear programming (LP) can be used to meet objectives such as flux maximization and
optimal growth. Moreover we show that Petri Nets are useful in biochemical networks representation and for steady state pathways
identification. Results obtained by studying the robustness of Escherichia coli metabolic network with sensitivity analysis tools
are presented. Finally we suggest how computational models of biochemical networks can be employed in metabolic engineering
design.
c© 2008 Published by Elsevier Ltd
Keywords: Biological networks; Metabolic networks; Petri nets; Linear programming
1. Introduction
The advent of high throughput technologies in the biological research pipeline has enabled genome sequencing,
proteome inspections and gene chip analyses, leading to the identification of living systems molecular components
and their interactions [1]. Entire genomic DNA sequences are now available for a continuously growing number of
organisms and, although functional assignments to the corresponding genes are not yet completed, this information
can be used to derive the structure and properties of biological networks associated with living systems [2].
The relationship between genomics (network topology) and cellular functions (network properties) is hierarchical
and involves many layers. Fig. 1 shows the “virtual” process required for building a biological network from the
integration of genome sequences and experimental data. The first step of this process consists in the identification of
a “list of parts” ranging from genes, detected by genomic sequencing, to proteins, detected by proteome inspections,
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Fig. 1. Process of “virtual” biological network reconstruction. Traditional 1D genome annotation leads to the “list of parts”, which is the basis for
the annotation of molecular interactions. The 2D annotation of genomes returns a so-called matrix of interactions.
and metabolites, identified by biochemical measurements. The second step consists in characterizing the matrix of
interactions, which is a 2D annotation of the interactions among elements belonging to the “list of parts”.
The list of parts together with the matrix of interactions constitute the starting point for Systems Biology, a new
paradigmatic approach in life sciences, that focuses on how living systems complex properties emerge from the
reciprocal interactions of the single molecular entities [3]. To achieve this difficult task Systems Biology integrates in
its methodological approach experimental and modeling procedures [4].
Mathematical model building in biology is likely to differ, at least initially, from that practiced in physics and
chemistry. In the latter fields the scientist could employ equations based on fundamental and established physical
theories and concepts. Computer models of complex processes involved in physico–chemical sciences use information
both on the properties of each component of the system as well on their reciprocal interconnectivity.
In spite of impressive bioinformatics databases collecting a wide spectrum of experimental measurements, we
cannot obtain all of the information needed to build a computer model of a whole cell at the level of description typical
of physics and chemistry [5]. Surely one day this goal will be achieved, but at present a different approach is needed,
if we want useful computer models of whole cells. In the absence of detailed information, an alternative approach
could be based on the fact that cells are subjected to certain constraints, limiting their feasible states. Imposing these
constraints one can determine what is possible to a cell and what is not. This iterative constraint definition leads to the
definition of a feasible state space containing all plausible behaviors of the cell. The resulting space could be further
analyzed in order to find the state which is optimal under certain criteria.
This approach is particularly useful for metabolic networks, in which the wealth of currently available data can be
used in the creation of models permitting simulation and optimization of these systems [6].
Computational models of biological networks will help us to deeply understand the development of living
organisms, and also constitute the basic step towards the definition of strategic control interventions policies. The
latter could have a direct exploitation in therapy, inducing a shift in the state of a biological network from pathology,
such as cancer and neurodegenerative diseases, to health [7].
Models inspired by graph theory are employed to formalize biological network structure, to predict the systemic
response arising from specific stimulations and to identify those molecules involved in system control.
It is common practice to distinguish three kind of biological networks, based on the properties of nodes and their
interactions. Note that this classification is based on biological concepts and is not completely correct, because nodes
belonging to different networks could interact together.
(1) Metabolic networks [8,4]: graphs whose nodes are associated with biochemical compounds, and arcs to
biochemical reactions catalyzed by enzymes performing matter transformations.
(2) Transcription regulatory networks, whose nodes are associated with genes and directed arcs represent activations
or inhibitions of genetic transcription [9].
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Fig. 2. (a) A graphical representation of a simple biological system; (b) The metabolic network associated with the biological system.
(3) Signalling networks, whose nodes represent biological macromolecules and where the information flow through
the arcs transduces a stimulus in a systemic response [10].
In this paper we introduce a general graph based model of biological networks which comprises the metabolic,
regulatory and signalling aspects described above. We then focus our attention on the study of the steady state
behaviors of metabolic networks, which are considered as particular instances of the general biological network model.
In particular we show how metabolic networks optimization techniques based on linear programming (LP) can be
used to meet objectives such as flux maximization and optimal growth. Moreover we show that Petri Nets are useful
in biochemical network representation and steady state pathway identification.
We present the results obtained by studying a relatively simple organism, namely the Escherichia coli, whose
network is well characterized [11,12]. Finally we suggest how to use computational models of biochemical networks
in metabolic engineering design [13].
The rest of the paper is organized as follows: in Section 2, we introduce the general formulation of a biological
system as a graph, whereas in Section 3 we focus our attention on the definition of metabolic networks and their
characterization through stoichiometric matrices. In Section 4 we describe the steady state linear optimization problem
for flux maximization and optimal growth and the related sensitivity analysis. In Section 5 we consider a case study by
analyzing the problem of maximizing the biomass production of E. coli, and evaluating metabolic network robustness
with respect to gene deletions. In conclusion Section 6 focuses on the application of computational metabolic models
in metabolic engineering.
2. Biological systems as graphs
A biological network is represented as a tripartite hyper-graph Λ = {D, P,M, I }, where D represents the set of
nodes associated with genes (more precisely to gene transcripts), P is the set of nodes associated with proteins, M
is the set of nodes associated with metabolites and I is the set of arcs, where arc(i, j) ∈ I represents the interaction
between nodes i and j (see Fig. 2(a)).
The biological meaning associated with each arc(i, j) is directly correlated to the nature of nodes i and j . In
particular we have:
(1) IDP = {(i, j) ∈ I |i ∈ D, j ∈ P}, is the set of arcs, associated with the ribosomal synthesis of protein j codified
by gene i . In order to take into consideration RNA mediated events like alternative splicings, we assume that each
gene could codify for more than a single protein.
(2) IPD = {( j, i) ∈ I |i ∈ D, j ∈ P} is the set of arcs representing the regulation of the expression of gene i actuated
by protein j . These arcs codify gene expression inhibitions or activations, and are of particular interest when
studying transcriptional regulatory networks.
(3) IPP = {(i, j) ∈ I |i ∈ P, j ∈ P}: this set of arcs represents physical interactions between proteins, as for example
the formation of protein assemblies. These set of arcs could be identified by scanning specific databases containing
experimental measurements of protein–protein interactions [14].
(4) IMD = {(k, i) ∈ I |k ∈ M, j ∈ D} is the set of arcs representing the interactions between metabolite k and gene j
when k can modify the nature of j , altering the DNA sequence through mutations. Although these interactions are
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Fig. 3. The reaction of glucose (glu) phosphorilation, mediated by ATP and ADP, to glucose-6-phosphate (g6p) catalyzed by the enzyme
glucokinase (gk). We report its representation with chemical equations and graphs.
critical for studying neo-plastic pathologies, in which particular chemicals called theratogens induce mutagenesis,
we will exclude this set of arcs from the analysis of the following sections because these phenomena are outside
the aim of our work.
(5) IMP = {(k, j) ∈ I |k ∈ M, j ∈ P}, is the set of arcs which represent interactions occurring between metabolite k
and protein j when j takes k as input in order to produce another metabolite. In this case k is called substrate or
reagent of j .
(6) IPM = {(k, j) ∈ I |k ∈ M, j ∈ P} is the set of arcs which represent interactions occurring between metabolite k
and protein j . In this case j produces k and k is called product of j . As we will see in more detail IPM and IMP
are the interactions of interest when studying metabolic networks.
In the next section the analysis of biological systems will be focused on metabolic networks.
3. Metabolic networks and stoichiometric matrices
The metabolic network associated with a biological system can be defined as the bipartite sub-graph N =
{P,M, IMP , IPM } of Λ (see Fig. 2(b)), where P ∈ P contains the subset of proteins having metabolic functions,
and more formally:
P = {i, j ∈ P|(i, k) ∈ IPM , (k, j) ∈ IMP } (1)
where IMP represents the arcs connecting reagents to the enzymes processing them, and IPM the arcs connecting
enzymes to their product metabolites.
In biochemistry metabolic reactions are represented using chemical equations. In our hyper-graph model each
enzyme k ∈ P is associated with a biochemical reaction rk = (Ik, Ok) where Ik = {i ∈ M |(i, k) ∈ IMP } and Ok ={ j ∈ M |(k, j) ∈ IPM } (see Fig. 3). Without loss of generality, we model all the metabolic reactions as irreversible:
in fact reversible reactions are modeled as a set of two irreversible ones, i.e. the reaction A + B ↔ C is modeled as
A+ B → C and C ← A+ B. The structure of N describes the complex set of chemical reactions of the metabolism,
where the products of one reaction can be the reagent of another reaction. A path in N corresponds to a chain of
interconnected biochemical reactions called biochemical pathway. Just like a production system, a metabolic system
interacts with the environment by receiving input (nutrient metabolites) and producing outputs (output metabolites),
which are absorbed by and are discarded to the cellular environment through exchange reactions (see Fig. 2).
The structure of the metabolic network N is easily described by the (m×n)matrix S, wherem = |M | and n = |P|,
whose elements si j are given by:
si j =

−wi j if (i, j) ∈ IMP+wi j if (i, j) ∈ IPM
0 if (i, j)! ∈ IMP
⋃
IPM
(2)
where wi j represents the number of moles of i ∈ M that are converted by reaction j if (i, j) ∈ IMP , or the number of
moles of i ∈ M produced by the j th-reaction if (i, j) ∈ IPM . The Stoichiometric matrix S is a fundamental element
for metabolic network models, since the analysis of the S matrix subspaces based on Linear Algebra [15] reveals
information about stationary behaviors and the conservation of chemical concentration.
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Fig. 4. The different representations of metabolic networks. (a) the list of reactions; (b) stoichiometric matrix; (c) the corresponding Petri net.
3.1. Petri net representation of metabolic networks
Petri net [16] theory is a mathematical formalism originally proposed to model, analyze, and simulate discrete event
systems with inherent concurrency [17,18]. The simplest kind of Petri Net is a bipartite digraph, i.e. a graph with two
types of nodes, and directed arcs connecting nodes of different types. The two types of nodes are called places,
represented as circles, and transition, represented as boxes; Hence this type of net is also known as a place–transition
net. Places may be marked by an integer number of tokens. The overall state of a Petri Net of p places at time t is
represented by a vector of size p defining the marking s(t) on each place. In more formal terms a place–transition
Petri Net PN is represented by a quadruple PN = {PL , T, f, s0} where:
• PL and T are finite, nonempty, and disjoint sets. PL is the set of places. T is the set of transitions.
• f : (PLxT )⋃(T x PL) −→ No represents a mapping of the set of directed arcs connecting places and transitions,
weighted by non-negative integer values.
• s0 : PL −→ No gives the initial state of the net which corresponds to a marking vector.
The places from which the arcs originate are called input places, whereas the places at the end of the arcs are called
output places. Notice that a transition can fire if and only if there are enough tokens in their input places. Petri Net can
be used for representing metabolic network. In fact the metabolic network N could be viewed as a place–transition
Petri net PN(N ), where M , the metabolites, represent the set of places PL and the set P , containing the enzymes, is
associated with the set of transitions T . The Stoichiometric matrix S also corresponds to the incidence matrix of the
Petri Net associated with the metabolic network N .
In Fig. 4 we give as an example a metabolic network with 7 metabolites, of which 4 internal (A, B,C, D) and 3
external (Aext, Bext, Dext), and with 9 different metabolic enzymes (p1, p2, . . . , p9). The reactions which transport
nutrients into the system (p1 in Fig. 4) together with the reactions which transport products out of the system (p2
and p3, in Fig. 4) are exchange reactions. All the remaining reactions, not involving interactions with the external
environment, (from p4 to p9 in Fig. 4) are called internal reactions.
S. Lanzeni et al. / Computers and Mathematics with Applications 55 (2008) 970–983 975
4. The steady state linear optimization problem
In this section of the paper we focus on how optimization techniques, based on linear programming (LP) [19], can
be used to meet objectives such as flux maximization and optimal growth. Our first aim is to define the optimization
model for maximizing a particular linear cost function with Z (e.g. a function of growth rate) on a given metabolic
system. The decision variables are represented by fluxes v j
∨
j ∈ P , associated with a metabolic reaction r j ∈ R.
A flux v j represents the reaction rate, i.e. the number of molecules, measured in moles, that flow through transition j
during a unitary time step. We are interested in optimizing the metabolic network N by studying the steady state of
the system, i.e. the condition in which the chemical concentrations of each metabolite mi ∈ M , denoted by [mi ], do
not change with respect to time:
d[mi ]
dt
= 0.
In a Petri net model [mi ] corresponds to the marking of the place i , and the steady state constraint is implemented by
searching for the sequence of transitions which have a total null effect on the marking of N . Therefore, this sequence of
transitions corresponds to the T-invariants of the Petri net N . In the context of metabolic Petri nets, T-invariants stand
for multi-sets of chemical reactions, which have a total zero effect on a given distribution of chemical compounds’
concentrations. A T-invariant corresponds to a possible path through the network, named extreme pathways [4]. A
T-invariant v ∈ R|R| is called minimal T-invariant if it satisfies the linear system:{
Sv = 0
v ≥ 0 v ∈ R|R| (3)
and any v′ ∈ R|R| such that Sv′ = 0 we have supp(v′) ⊃ supp(v), where supp(v) is the support of v describes the
set of nonzero components in v. The set of minimal T-invariants forms a basis for the generation of other T-invariants.
All the possible cyclic system behaviors may be described by the convex combination of minimal T-invariants. The
computation of minimal T-invariants ∈ R|R|, which form a unique generating system, leads back to the problem of
solving systems of linear equations in non-negative integer variables. This problem is solvable by a non-deterministic
Turing machine in polynomial time meaning that the problem is NP, and can also be demonstrated that the problem is
NP-complete [19].
In a Petri net, transitions could fire infinite times, and in order to find the optimal flow through metabolic reactions,
we have to add other constraints. Additional boundary constraints derive from physico–chemical features of metabolic
enzymes j ∈ P , which show a specific maximum flux capacity, named vmaxj , and a minimum flux vminj . In our
case, vminj = 0,∀ j ∈ P because, as pointed out before we model all the reactions as irreversible ones. The value
of vmaxj can be specified for each enzyme j ∈ P which catalyzes an exchange reaction, i.e. nutrient and product
metabolites. It represents the maximum quantity of chemical transformation that the network can afford, and derives
from experimental biochemical assays.
The intersection of (3) with lower and upper bound constraints defines the feasible space of metabolic stationary
states corresponding to the possible metabolic behaviors. Note that additional constraints affect metabolic network
evolution, for example kinetic values and saturation constants, but unfortunately we do not have complete knowledge
about these constraint parameters. Indeed, if this would be the case, each behavior, representing a different phenotype,
could be exactly determined on the basis of component list, biochemical properties of components, and imposed
constraints. In the absence of these additional constraints, we are left with the feasible region represented by a cone,
whose edges become a set of unique, systemically defined metabolic pathways, namely the Extreme Pathways (see
Fig. 5). All the steady state metabolic flux distributions are therefore mathematically confined to a feasible region
defined by the stoichiometric matrix, and under particular conditions the optimal phenotype can be determined by
using LP. Indeed we are interested in finding a particular metabolic flux distribution optimizing a specific biochemical
objective (e.g. the biomass production, the ATP usage and consumption, the oxygen uptake and the pH of the
environment in which the micro-organism lives). The objective function is linear with respect to v, and its coefficients
are defined for each variable accordingly to its relevance. Supposing that a metabolite is a pharmaceutical molecule to
be produced, then its coefficient is larger [20,21]. This leads to the formulation of the following Linear Programming
(LP) problem:
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Fig. 5. The feasible space of metabolic network steady states is determined by imposing constraints. (a) mass balance constraints; (b) capacity
constraints.
max
{
Z =
n∑
i=1
hivi
}
with
{
Sv = 0
vmini < vi < v
max
i .
(4)
Many authors [22,23] solved the problem of maximizing cellular growth, where the objective function has all the
coefficients equal to zero except the one associated with biomass production.
4.1. Sensitivity analysis
If some constraint in (4) varies, the optimal flux vector could qualitatively change, by activating or inactivating
some reactions. The shape of the feasible region can change with respect to genotype alterations or with respect to
single nucleotide polymorphisms (SNPs) [24]. The first case means that a cell carries a mutation which inactivates the
corresponding metabolic enzyme and therefore its flux is constrained to zero. SNPs, which are the principal origin of
intra-species variability, correspond to little differences in genotype differentiating the kinetic parameters of enzymes,
and therefore they affect the shape of steady state feasible region. In order to study the effect of parametric variations,
LP sensitivity analysis can be employed. Of particular interest is the sensitivity and parametric analysis of the problem
with respect to the bound constraints. This is of critical importance because using genetic engineering, the properties
of any enzyme j ∈ P , which catalyzes an exchange reaction rk ∈ R, can be altered through the modification of the
value vmaxj of an active constraint. According with these considerations it is clear that the shadow prices γvmax , which
indicate the relative variation of solution cost (dZ ) with respect to the right-hand side of the constraint (dvmaxj ), give a
fundamental indication in identifying the enzyme to be modified. The larger the shadow price is, the more convenient
it is to modify that particular enzyme using genetic engineering.
The duality condition hv = γ vmax reflects the linearity of the relation between the cost function z = hv and the
shadow prices γ . This relationship is linear and has a discontinuous nature. Plotting the value of cost function Z with
respect to the right-hand side of the i th constraint, we obtain a piecewise linear function, where the slope of the linear
relationship remains the same in a specific range of constraint variation. In a region where the slope does not change,
the metabolic network remains in the same state but, there are particular thresholds of vmaxj that trigger the transition
to another metabolic state.
Shadow prices γm associated with the metabolite m ∈ M are instead associated with the variation of the objective
function with respect to a modification in the steady state condition for such a metabolite. These parameters are
relevant for the construction of “phenotype phase analysis” diagram. Phenotype phase analysis was developed from
Varma [25] by considering all the possible variations in two constraining variables. Two metabolic fluxes vi and v j are
defined as two axes on an (x, y) plane, and the optimal flux distributions are calculated for all the points in the plane.
Into the Cartesian plane there are a finite number of qualitatively different metabolic phenotypes, resulting in the
definition of different regions, in which the optimal use of metabolism is different. The demarcations on these regions
are defined using a shadow price analysis by [25] that calculates shadow price throughout the two flux parameter
space. This procedure results in the definition of lines that demarcate regions of constant metabolite shadow prices,
that are defined as “phenotype phase planes” {P(1)(vi , v j ), P(2)(vi , v j ), . . . , P(q)(vi , v j )}.
The reduced cost analysis is also meaningful in metabolic networks. Reduced costs are the variations in cost
function (dZ) that results from the variation in modification of a variable coefficient (dh). In metabolic terms,
S. Lanzeni et al. / Computers and Mathematics with Applications 55 (2008) 970–983 977
Fig. 6. Profile of the flux variable’s entity for the optimal biomass production in the core E. coli metabolism.
particularly in the biomass maximization example, reduced costs represent the net cost of using a reaction that is
not included in the current solution. In the next section we will see an application of these analyses to a real microbial
metabolic network.
5. E. coli metabolism analysis
In order to illustrate the specific features of LP formulation in biochemical problems, we analyze the optimization
of biomass production of a micro-organism, called E. coli, widely used in industrial applications because of its simple
growth conditions. In the following part of the paper, for the sake of simplicity, we will first consider a reduced E. coli
metabolic network. This network allows us to illustrate the complex behaviors of E. coli metabolism with a reduced
number of reactions. The reduced metabolic network [26] is called E. coli “core” metabolic network. The results
obtained by analyzing the complete metabolic network will then follow. For lack of space we do not report all the
details about our metabolic models, and we direct the interested reader to the URL www.life.disco.unimib.it, where
supplementary material is available.
5.1. E. coli core metabolic network
The core metabolic network is represented by a stoichiometric matrix composed by 58 internal metabolites, 14
external metabolites and 114 reactions (28 exchange and 86 internal). The steady state condition is imposed and
the lower and upper bounds are fixed. The objective is to maximize the biomass production, representing cell growth,
defined by introducing a new metabolic flux vgrowth associated with the virtual metabolic reaction converting precursor
metabolites into biomass:∑
k
dkxk→vgrowth biomass (5)
where: dk represents the amount of metabolite k which contributes to the biomass composition, xk represents the
molar quantity of metabolite k produced. vgrowth is the flux associated with the reaction that virtually converts all the
biosynthetic precursor metabolites k ∈ M into biomass.
The optimal solution for the LP problem (see Eq. (4)), using Eq. (5) as objective, is depicted in Fig. 6, where the
optimal steady state flux distribution is shown.
This solution leads to the identification of the subset of those metabolic enzymes involved in biomass production,
meaning that every environmental condition activates different sets of enzymes. This result confirms gene expression
measurements and it will be further enhanced in the analysis of the E. coli complete metabolic network.
An important aspect that can be studied is the evaluation of the metabolic network robustness. Biological systems
demonstrate in fact robustness with respect to alterations, losing their functionalities only corresponding to specific
alterations. For this reason biological robustness is an important feature of a biological system, that must be taken into
account, in particular when hypothesizing a pharmacological intervention.
We performed a single gene deletion screening for predicting the metabolic phenotype of the resulting E. coli
clones. Note that the deletion of gene j corresponds to setting its upper bound vmaxj to zero. The biomass production
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Fig. 7. Effects of single gene deletions on E. coli cellular growth. The ordinate axis on the left represents the biomass production (growth rate),
whereas the y-axis on the right represents the value of fluxes carried by the enzymes in the optimal solution without deletion.
obtained by the virtual single deletion of 66 genes in the E. coli core metabolic network, is depicted in Fig. 7. On
the left y-axis we report the rate of cellular growth for the deleted network, whereas on the right y-axis we report the
metabolic flux passing through that reaction in the original undeleted network. We can see that in 10 cases the deletion
causes cellular death (null biomass production), in 8 cases it leads to a “retarding” phenotype, i.e. a small decrease in
cellular growth, and in 47 cases the gene deletion has no effect on cellular growth. There is only one case (ATPM)
whose deletion produces an increase in cellular growth.
These results can be interpreted as follows: enzymes carrying a zero flux obviously produce, in the case of their
deletion, a zero effect on the biomass production; However there is no correlation between the entity of the flux and
the effect of the corresponding gene deletion on biomass production. This effect is more correlated to the position
of the deleted reaction in the network topology than to the dimensions of its metabolic flux. The exception given by
ATPM has the following meaning: ATPM is an enzyme that catalyzes the reaction:
ATP→ ADP+ P I
which represents the usage of ATP, i.e. energy, for maintaining cellular homeostasis. The lesser the energy an organism
requires for its homeostasis, the more are the matter and energy that can be employed for its growth.
Following the same principles defined for the single gene deletion, we performed virtual double deletion by
bounding two fluxes (vi and v j ) to zero and subsequently evaluating cellular growth. From this analysis we obviously
excluded all the genes that showed lethality, i.e. null cell growth, if singularly deleted. Growth rate for 400 double
deleted E. coli clones are depicted in Fig. 8. Each mutant clone is represented by a rectangle positioned into the
matrix, and its level of cellular growth is showed by its color. We can observe that some genes, that in single deletion
were not lethal, cause cellular death if associated with a particular other gene deletion. This situation depends on the
progressive elimination of paths in the network N producing metabolite precursors of biomass.
In Fig. 9 we report two opposite examples of relationship between the defined objective, i.e. cell growth, and
a specific metabolic flux vmaxj . Note that, as illustrated in the figure, there are different phases in which cellular
growth increases linearly with different slopes by varying the flux carried by NUOA, with a final phase that seems
to be a saturation. NUOA is a NADH dehydrogenase enzyme involved in the oxidative phosphorilation, a series of
reactions that are used by the cell to produce energy. The more energy the metabolism is able to produce, more are
the resources that could be employed for cellular growth, until a saturation of the other pathways converting energy in
biomass precursors is reached. In the part (b) of Fig. 9 we also show the relationship existing between the homeostasis
maintenance requirements and the cellular growth of E. coli, that are represented by the flux carried by ATPM. In this
case the trend is opposite with respect to the previous, resulting in a progressive decrease in cellular growth subsequent
to an increase in the energy required for maintenance.
S. Lanzeni et al. / Computers and Mathematics with Applications 55 (2008) 970–983 979
Fig. 8. Matrix of double deletion impact on cellular growth. Each E. coli deleted clone is colored according to its viability (black = null biomass
production, white = maximum biomass production).
Fig. 9. (a) The linear relationship, with negative slope, between the biomass production and the cellular energy maintenance requirements
represented by the ATPM fluxes (b) the relationship between the cellular growth and the capacity of phosphorilative oxidization represented
by NUOA flux.
We conclude the analysis of this metabolic network showing, in Fig. 10, the 2D graph representing the phenotype
phase planes, obtained as described in [25]. Glucose and oxygen uptakes were collocated on the two (x, y) axes. The
analysis results in the delineation of five different regions (or “phases”) representing qualitatively different metabolic
states in which E. coli could operate. We can recognize that moving from P(2) to P(5), the difference lies in the oxygen
uptake, that causes the decreasing microbial ability in using the glucose-carbon source for growth. Oxygen is used by
the metabolic network for the oxidization of carbon source (in this case glucose); if the uptake of oxygen is limited by
some external conditions, the cell cannot use all its growth potential.
5.2. E. coli complete metabolic network
The complete stoichiometric matrix of E. coli metabolism is composed by 536 metabolites and 954 reactions. We
implemented this model in GAMS, by parsing the list of metabolic reactions published by Fong [26]. The objective
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Fig. 10. Phenotype phase plane diagram of E. coli core metabolism with respect to oxygen and glucose uptake. Five different regions of constant
metabolite associated shadow prices are recognizable; They correspond to different metabolic capabilities of the network characterized by the
capacity of oxidizing nutrients.
Fig. 11. Profile of the flux variables’ entities for the optimal solution of biomass production maximization in complete E. coli metabolic network.
function is the same as that defined for the E. coli core network. The optimal solution for this LP problem is depicted
in Fig. 11. We can observe that, as suggested in the previous subsection, in the optimal solution only a subset of
metabolic network reactions are activated for producing biomass. These results are confirmed by the general trend of
gene expression measurements obtained experimentally. In Fig. 12 the values of shadow prices associated with each
enzyme involved in E. colimetabolism are reported: most enzymes show a shadow price near zero in accordance with
their low influence on biomass, but it shows clearly that two enzymes are critical: GLCxt for glucose cell input and
CO2xt for carbondioxide cell output. These are key transporters that, if modified with genetic engineering will cause
an increase in biomass production.
6. A metabolic engineering application
The aim of this section is to show how LP and Petri nets based models can be used in the design of metabolic
engineering intervention. Metabolic engineering is concerned with the design of cell cultures aimed at maximizing
the production of particular compounds. If the metabolic network that has been engineered is already able to produce
the desired compound, the procedure consists in the identification of genetic modification needed to direct metabolic
flux towards this metabolite. When the desired compound is not produced naturally a designed pathway must be
introduced, through the addition of new enzymes to the existing network. This addition is performed using genetic
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Fig. 12. Shadow prices of upper bound flux constraints in the complete E. coli metabolic network. It is possible to recognize the transporters to
modify via genetic engineering, in order to increase biomass production.
Fig. 13. The two biochemical pathways leading to amorpha-4,11-diene synthesis.
engineering, which allows for the insertion of new genes, that can be taken from different organisms. These practices
have recently seen increased utility in the medical arena. The modeling of metabolic pathways could be applied
to gain a better understanding of molecular disease mechanisms in a variety of cellular, subcellular, and organ
systems, including liver, heart, mitochondria, and cancerous cells. Moreover metabolic pathway engineering has
been used to generate cells with novel biochemical functions for therapeutic use, among these for the production
of pharmacological molecules.
We present a case study concerning the artificial modification of E. coli in order to produce amorpha-4,11-diene, a
precursor of artemisin belonging to the class of terpenoids, which comprise numerous commercial flavours, fragrances
and medicine [27,28]. In order to produce the class of molecules to which artemisin belongs to, there are two
biosynthetic pathways existing in nature. The mevalonate pathway (mev) is used by eukaryotes and plants, whereas
the deoxyxylulose 5-phosphate (dxyl5p) is used prevalently by prokaryotes.
In Fig. 13 the existing pathways for the synthesis of amorpha-4,11-diene precursors are illustrated. Note that these
two pathways correspond to the two minimal T-invariants of the Petri net (obtained by adding closing loops and solv-
ing problem (3)). Since E. coli belongs to prokaryotes, in its metabolism only the dxyl5p pathway is present, whereas
the eukaryotic mevalonate pathway is absent. For this reason a metabolic engineering intervention could be the intro-
duction of the mevalonate pathway, present in eukaryotic cells, to increase the production of ipdp and dmpp. We added
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Table 1
Abbreviations for enzymes depicted in Fig. 13
Abbreviations Real enzyme names
atoB Acetoacetyl-CoA Thiolase
HMGS hmg coa synthase
THMGR Truncated hmg coa reductase
ERG12 Mevalonate kinase
ERG8 Phosphomevalonate kinase
MVD1 mev pp decarboxilase
DXPS dxyl5p synthase
DXPRIi dxyl5p reductoisomerase
MEPCT 2me4p cytidylyltransferase
CDPMEK 2p4c2me kinase
MECDPS 2mecdp synthase
MECDPDH 2mecdp dehydratase
IPDPS ipdp synthase
DMPPS dmpp synthase
IPPDIi ipdp D-isomerase
DMATT Dimethylallyltranstransferase
GRTT Geranyltranstransferase
ADS Amorpha-4-11-diene synthase
Table 2
Abbreviations for metabolites depicted in Fig. 3
Abbreviation Real metabolite names
pyr Pyruvate
g3p Gliceraldeide 3-phosphate
accoa Acetil coenzyme A
aaccoa Aceto acetyl Coenzyme A
hmg coa Hydroxymethylglutaryl Coenzyme A
mev Mevalonate
mev p Mevalonate phosphate
mev pp Mevalonate bis phosphate
ipdp Isopentenyl diphosphate
dmpp Dimethylallyl diphosphate
grdp Geranyl diphosphate
frdp Farnesyl diphosphate
amorph Amorpha-4,11-diene
dxyl5p 1-deoxy-D-xylulose 5-phosphate
2me4p 2-C-methyl-D-erythritol 4-phosphate
4c2me 4-diphosphocytidyl-2-C-methyl-D-erythriol
2p4c2me 4-diphosphocytidil-2-C-methyl-D-erythritol-2-phosphate
2mecdp 2-C-methyl-D-erythritol 2,4cyclopyrophosphate
h2mb4p 1-hydroxy-2-methyl-2-(E)-butenyl 4-pyrophosphate
the genes required for the synthesis of mevalonate pathways enzymes. In Fig. 13 the inserted genes are highlighted
together with the metabolites they synthesize. Abbreviations used in Fig. 11 are explained in Tables 1 and 2. In the
resulting metabolic network we predicted the effects of these engineering interventions. The production of amorpha-
4,11-diene of the complete metabolic network by E. coli optimizing the biomass production (see Section 5.2) was
equal to zero, while optimizing the production of amorpha-4,11-diene through the maximization of GRTT flux yielded
a value, 0.02. After the introduction of the new pathway, the production of amorpha-4,11-diene increases to 0.57, while
the biomass production decreases. This means that the addition of exogenous genes and metabolites surely alter the
normal microbial homeostasis, since the synthesis of new enzymes require additional energy for protein synthesis.
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7. Conclusions and future works
In this paper we showed how PN models and linear programming can be used as a valuable tool for the analysis
and optimization of metabolic networks.. In particular, through the solution of LP models, we were able to identify
enzymes relevant in obtaining a particular phenotype. The associated phenotype phase associated with E. coli
metabolism plane was obtained by performing sensitivity analysis. Constrained linear optimization was also used
to analyze the role of each enzyme in determining cellular growth. Robustness analysis has been conducted for
predicting the effects of single and double gene deletions. More appropriate algorithms for multiple deletions analysis
are currently under development. A metabolic engineering application has also been addressed. Results obtained are
confirmed by experimental evidences. Although steady state analysis is of relevance here, it cannot take into account
kinetic laws regulating the behavior of biological systems, which require the explicit modeling of time and uncertainty.
For these reasons future works in the study of metabolic network will concentrate on the dynamical behavior of
the networks, not assuming the steady state, and considering stochasticity. Petri nets and Stochastic Programming
techniques are promising candidates to sustain these investigations.
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